Mariner, LLC Neurocrine Biosciences Inc Transaction History

Mariner, LLC

$55.8 Billion
Q3 2024

A detailed history of Mariner, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Mariner, LLC holds 16,782 shares of NBIX stock, worth $2.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,782

Previous 19,889 15.62%

Holding current value

$2.55 Million

Previous $2.74 Million 29.44%

% of portfolio

0.0%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$114.58 - $153.15 $356,000 - $475,837	-3,107 Reduced 15.62%	16,782 $1.93 Million
Q2 2024 Aug 13, 2024	BUY	$130.86 - $143.19 $51,689 - $56,560	395 Added 2.03%	19,889 $2.74 Million
Q1 2024 May 15, 2024	BUY	$130.4 - $143.74 $312,568 - $344,544	2,397 Added 14.02%	19,494 $2.69 Million
Q4 2023 Feb 14, 2024	BUY	$106.07 - $132.76 $649,042 - $812,358	6,119 Added 55.74%	17,097 $2.25 Million
Q3 2023 Nov 13, 2023	BUY	$94.02 - $117.1 $62,993 - $78,457	670 Added 6.5%	10,978 $1.24 Million
Q2 2023 Aug 11, 2023	BUY	$89.53 - $104.87 $35,364 - $41,423	395 Added 3.98%	10,308 $972,000
Q1 2023 May 12, 2023	SELL	$94.11 - $123.02 $64,371 - $84,145	-684 Reduced 6.45%	9,913 $1 Million
Q4 2022 Feb 14, 2023	SELL	$106.72 - $127.06 $126,249 - $150,311	-1,183 Reduced 10.04%	10,597 $1.27 Million
Q3 2022 Nov 10, 2022	BUY	$92.03 - $107.81 $11,871 - $13,907	129 Added 1.11%	11,780 $1.25 Million
Q2 2022 Aug 15, 2022	BUY	$75.79 - $100.07 $64,800 - $85,559	855 Added 7.92%	11,651 $1.14 Million
Q1 2022 May 13, 2022	BUY	$72.45 - $94.81 $782,170 - $1.02 Million	10,796 New	10,796 $1.01 Million
Q3 2019 Nov 13, 2019	SELL	$83.82 - $101.5 $221,033 - $267,655	-2,637 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$72.24 - $91.27 $1,228 - $1,551	-17 Reduced 0.64%	2,637 $223,000
Q1 2019 May 15, 2019	BUY	$69.31 - $91.53 $183,948 - $242,920	2,654 New	2,654 $234,000

Others Institutions Holding NBIX

# of Institutions

638

Shares Held

93.8M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14.5B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account